Therefore, it seems reasonable to suggest that T1DM patients carrying the A/A genotype may have a lower risk for developing AH due to a decreased IFIH1 gene expression and, consequently, a lesser inflammatory environment. The gene discussed is IFIH1; the disease is type 1 diabetes mellitus.